Olema Pharmaceuticals (OLMA) Current Leases (2021 - 2026)

Olema Pharmaceuticals (OLMA) has 6 years of Current Leases data on file, last reported at $956000.0 in Q1 2026.

• On a quarterly basis, Current Leases fell 6.73% year-over-year to $956000.0 in Q1 2026; TTM through Mar 2026 was $956000.0, a 6.73% decrease from a year earlier, with the FY2025 full-year figure at $1.1 million, down 4.1% from the prior year.
• Current Leases for Q1 2026 stood at $956000.0, down from $1.1 million in the prior quarter.
• Over the last five years, Current Leases for OLMA reached as high as $1.2 million in Q4 2024 and fell as low as $798000.0 in Q2 2023.
• Historically, Current Leases has averaged $1.0 million across 5 years, with a median of $1.1 million in 2024.
• Across the five-year window, Current Leases slipped 25.97% in 2023 and soared 38.22% in 2024, its largest moves.
• Year by year, Current Leases stood at $1.0 million in 2022, then dropped by 2.66% to $988000.0 in 2023, then increased by 18.62% to $1.2 million in 2024, then retreated by 4.1% to $1.1 million in 2025, then dropped by 14.95% to $956000.0 in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $956000.0 in Q1 2026, $1.1 million in Q4 2025, and $1.2 million in Q3 2025.